Previous close | 88.83 |
Open | 88.66 |
Bid | 79.23 x 1100 |
Ask | 91.90 x 1000 |
Day's range | 87.96 - 89.52 |
52-week range | 69.44 - 90.00 |
Volume | |
Avg. volume | 941,822 |
Market cap | 43.589B |
Beta (5Y monthly) | 0.68 |
PE ratio (TTM) | 41.95 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.27 (0.30%) |
Ex-dividend date | 14 May 2024 |
1y target est | N/A |
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.